Literature DB >> 28496597

Typical Flutter Ablation as an Adjunct to Catheter Ablation of Atrial Fibrillation.

Dipen Shah1.   

Abstract

During the past decades there has been a consistent evolution of both surgical and catheter-based techniques for the treatment of stand-alone atrial fibrillation, as alternatives or in combination with anti-arrhythmic drugs. Transcatheter ablation has significantly improved outcomes, despite often requiring multiple procedures and with limited success rates especially in presence of persistent atrial fibrillation. Surgical procedures have dramatically evolved from the original cut-and-sew Maze operation, allowing nowadays for closed-chest epicardial ablations on the beating heart. Recently, the concept of a close collaboration between the cardiac surgeon and the electrophysiologist has emerged as an intriguing option in order to overcome the drawbacks and suboptimal results of both techniques; therefore, the hybrid approach has been proposed as a potentially more successful strategy, allowing for a patient-tailored therapeutical approach. We reviewed the recent advancements either from the transcatheter and surgical standpoint, with a peculiar focus on the current option to merge both techniques along with an up-to-date review of the preliminary clinical experiences with the hybrid, surgical-transcatheter treatment of stand-alone atrial fibrillation.

Entities:  

Year:  2008        PMID: 28496597      PMCID: PMC5398804          DOI: 10.4022/jafib.106

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  15 in total

1.  A COMPUTER MODEL OF ATRIAL FIBRILLATION.

Authors:  G K MOE; W C RHEINBOLDT; J A ABILDSKOV
Journal:  Am Heart J       Date:  1964-02       Impact factor: 4.749

2.  Mechanism of initiation of atrial flutter in humans: site of unidirectional block and direction of rotation.

Authors:  J E Olgin; J M Kalman; L A Saxon; R J Lee; M D Lesh
Journal:  J Am Coll Cardiol       Date:  1997-02       Impact factor: 24.094

3.  Class IC antiarrhythmic drug induced atrial flutter: electrocardiographic and electrophysiological findings and their importance for long term outcome after right atrial isthmus ablation.

Authors:  A Nabar; L M Rodriguez; C Timmermans; R van Mechelen; H J Wellens
Journal:  Heart       Date:  2001-04       Impact factor: 5.994

4.  Mechanism of spontaneous transition from typical atrial flutter to atrial fibrillation: role of ectopic atrial fibrillation foci.

Authors:  M H Hsieh; C T Tai; C F Tsai; W C Yu; W S Lin; J L Huang; Y A Ding; M S Chang; S A Chen
Journal:  Pacing Clin Electrophysiol       Date:  2001-01       Impact factor: 1.976

Review 5.  What is the relationship of atrial flutter and fibrillation?

Authors:  F X Roithinger; M D Lesh
Journal:  Pacing Clin Electrophysiol       Date:  1999-04       Impact factor: 1.976

6.  Catheter ablation of chronic atrial fibrillation targeting the reinitiating triggers.

Authors:  M Haïssaguerre; P Jaïs; D C Shah; T Arentz; D Kalusche; A Takahashi; S Garrigue; M Hocini; J T Peng; J Clémenty
Journal:  J Cardiovasc Electrophysiol       Date:  2000-01

7.  Nonpulmonary vein foci: do they exist?

Authors:  Dipen Shah; Michel Haissaguerre; Pierre Jais; Meleze Hocini
Journal:  Pacing Clin Electrophysiol       Date:  2003-07       Impact factor: 1.976

8.  Clinical significance of inducible atrial flutter during pulmonary vein isolation in patients with atrial fibrillation.

Authors:  Christoph Scharf; Srikar Veerareddy; Mehmet Ozaydin; Aman Chugh; Burr Hall; Peter Cheung; Eric Good; Frank Pelosi; Fred Morady; Hakan Oral
Journal:  J Am Coll Cardiol       Date:  2004-06-02       Impact factor: 24.094

9.  Evaluation of an individualized strategy of cavotricuspid isthmus ablation as an adjunct to atrial fibrillation ablation.

Authors:  Dipen C Shah; Henri Sunthorn; Haran Burri; Pascale Gentil-Baron
Journal:  J Cardiovasc Electrophysiol       Date:  2007-07-26

Review 10.  Mother rotors and fibrillatory conduction: a mechanism of atrial fibrillation.

Authors:  José Jalife; Omer Berenfeld; Moussa Mansour
Journal:  Cardiovasc Res       Date:  2002-05       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.